NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 87 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 205.18 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $130,000 | 0.0% | 137,458 | +40.9% | 0.00% | 0.0% |
| Q4 2015 | $130,000 | -40.1% | 97,558 | +2.4% | 0.00% | 0.0% |
| Q3 2015 | $217,000 | +41.8% | 95,316 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $153,000 | -13.1% | 95,316 | -14.0% | 0.00% | 0.0% |
| Q1 2015 | $176,000 | -20.0% | 110,800 | -4.9% | 0.00% | 0.0% |
| Q4 2014 | $220,000 | +42.9% | 116,490 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $154,000 | -9.4% | 116,490 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $170,000 | -1.7% | 114,838 | +22.7% | 0.00% | 0.0% |
| Q1 2014 | $173,000 | -10.8% | 93,603 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $194,000 | -23.0% | 93,603 | -1.4% | 0.00% | 0.0% |
| Q3 2013 | $252,000 | +11.0% | 94,935 | +11.8% | 0.00% | 0.0% |
| Q2 2013 | $227,000 | – | 84,936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|